Aerts JM - Search Results

1

Plasma chitotriosidase and CCL18 as surrogate markers for granulomatous macrophages in sarcoidosis.

Boot RG, Hollak CE, Verhoek M, Alberts C, Jonkers RE, Aerts JM. Boot RG, et al. Among authors: aerts jm. Clin Chim Acta. 2010 Jan;411(1-2):31-6. doi: 10.1016/j.cca.2009.09.034. Epub 2009 Oct 4. Clin Chim Acta. 2010. PMID: 19808030

2

The identification of type 1 Gaucher disease patients, asymptomatic cases and carriers in The Netherlands using urine samples: an evaluation.

Aerts JM, Sa Miranda MC, Wanzeller de Lacerda L, van Weely S, Donker-Koopman W, Brouwer-Kelder B, Jansen DC, van Leeuwen M, Schram AW, Tsiapara A, et al. Aerts JM, et al. Clin Chim Acta. 1991 Dec 16;203(2-3):349-61. doi: 10.1016/0009-8981(91)90308-y. Clin Chim Acta. 1991. PMID: 1838035

3

[Gaucher's disease; current developments in the treatment of lysosomal metabolic disease].

Hollak CE, Aerts JM, Goudsmit R. Hollak CE, et al. Among authors: aerts jm. Ned Tijdschr Geneeskd. 1991 Nov 16;135(46):2162-4. Ned Tijdschr Geneeskd. 1991. PMID: 1956441 Review. Dutch. No abstract available.

4

Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages.

Boot RG, Renkema GH, Strijland A, van Zonneveld AJ, Aerts JM. Boot RG, et al. Among authors: aerts jm. J Biol Chem. 1995 Nov 3;270(44):26252-6. doi: 10.1074/jbc.270.44.26252. J Biol Chem. 1995. PMID: 7592832 Free article.

5

Individualised low-dose alglucerase therapy for type 1 Gaucher's disease.

Hollak CE, Aerts JM, Goudsmit R, Phoa SS, Ek M, van Weely S, von dem Borne AE, van Oers MH. Hollak CE, et al. Among authors: aerts jm. Lancet. 1995 Jun 10;345(8963):1474-8. doi: 10.1016/s0140-6736(95)91037-9. Lancet. 1995. PMID: 7769902 Clinical Trial.

6

Purification and characterization of human chitotriosidase, a novel member of the chitinase family of proteins.

Renkema GH, Boot RG, Muijsers AO, Donker-Koopman WE, Aerts JM. Renkema GH, et al. Among authors: aerts jm. J Biol Chem. 1995 Feb 3;270(5):2198-202. doi: 10.1074/jbc.270.5.2198. J Biol Chem. 1995. PMID: 7836450 Free article.

7

Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.

Hollak CE, van Weely S, van Oers MH, Aerts JM. Hollak CE, et al. Among authors: aerts jm. J Clin Invest. 1994 Mar;93(3):1288-92. doi: 10.1172/JCI117084. J Clin Invest. 1994. PMID: 8132768 Free PMC article.

8

Pathogenesis of lysosomal storage disorders as illustrated by Gaucher disease.

Aerts JM, Van Weely S, Boot R, Hollak CE, Tager JM. Aerts JM, et al. J Inherit Metab Dis. 1993;16(2):288-91. doi: 10.1007/BF00710267. J Inherit Metab Dis. 1993. PMID: 8411983 Review. No abstract available.

9

Characterization of glucocerebrosidase in Greek Gaucher disease patients: mutation analysis and biochemical studies.

Michelakakis H, Dimitriou E, Van Weely S, Boot RG, Mavridou I, Verhoek M, Aerts JM. Michelakakis H, et al. Among authors: aerts jm. J Inherit Metab Dis. 1995;18(5):609-15. doi: 10.1007/BF02436006. J Inherit Metab Dis. 1995. PMID: 8598642

10

[The treatment of Gaucher's disease in The Netherlands using enzyme substitution therapy].

Hollak CE, van Oers MH, Maaswinkel P, Aerts JM, Goudsmit R. Hollak CE, et al. Among authors: aerts jm. Ned Tijdschr Geneeskd. 1996 May 11;140(19):1011-3. Ned Tijdschr Geneeskd. 1996. PMID: 8684492 Review. Dutch. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

461 results

Search Page

Filters